Evidence map›Paper›PMID 26691847›Full record

ArticleExperimental and clinical psychopharmacology2016

Impulsivity and polysubstance use: A systematic comparison of delay discounting in mono-, dual-, and trisubstance use.

Lara Moody, Christopher Franck, Laura Hatz, Warren K Bickel

Open access · greenAbstract readComparative Study
In one paragraph

Article in Experimental and clinical psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. A systematic review and meta-analysis of delay discounting and cannabis use.Experimental and clinical psychopharmacology · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Perceived reward certainty in the assessment of delay discounting.Journal of the experimental analysis of behavior · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Smoking Dependence, Time-Discounting, and Sustained Cessation Behavior: A Longitudinal Study of Predominantly Light Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lara MoodyVirginia Tech Carilion Research Institute.
Christopher FranckVirginia Tech Carilion Research Institute.
Laura HatzVirginia Tech Carilion Research Institute.
Warren K BickelVirginia Tech Carilion Research Institute.
Virginia Tech · USCarilion Clinic · US

Funding

Self-Control Improvement Intervention (SCII): Improving Abstinence in SmokersR01DA034755 · NIDA · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI BICKEL, WARREN K · 2013 to 2017
$3.6M
Executive Function Therapy for Stimulant AddictionR01DA024080 · NIDA · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI BICKEL, WARREN K · 2008 to 2012
$3.1M
NIDA NIH HHS R01 DA024080NIDA NIH HHS R01DA024080NIDA NIH HHS R01 DA034755NIDA NIH HHS R01DA034755NIDA NIH HHS R01DA034755-01A1S1
6 · The paper itself

Abstract

Understanding the association between polysubstance use and impulsivity is pertinent to treatment planning and efficacy. Delay discounting, a measure of impulsivity, supplies the rate at which a reinforcer loses value as the temporal delay to its receipt increases. Excessive delay discounting has been widely observed among drug-using individuals, though the impact of using more than 1 substance has been only minimally studied. Here, after controlling for demographic variables, we systematically compared delay discounting in community controls, heavy smokers, and alcohol- and cocaine-dependent individuals to assess the impact of non-, mono-, dual-, and trisubstance use. All substance-using groups discounted significantly more than did community controls (p < .05). Additionally, groups that smoked cigarettes in addition to another substance dependency discounted significantly more than did the group that smoked cigarettes only (p < .05). Last, trisubstance users who were alcohol-dependent, cocaine-dependent, and heavy cigarette smokers discounted significantly more than did heavy smokers (p < .01). However, trisubstance users did not discount significantly more than did any dual-substance group. Trisubstance use was associated with greater impulsivity than was monosubstance smoking but exhibited no greater impulsivity than did dual-substance use, suggesting a ceiling effect on discounting when more than 2 substances are in use. The present study suggests that smokers who engage in additional substance use may experience worse treatment outcomes, given that excessive discounting is predictive of poor therapeutic outcomes in several studies.

Indexed as

Delay DiscountingImpulsive BehaviorAdultAlcoholismCocaine-Related DisordersFemaleHumansMaleMiddle AgedTobacco Use Disorder

Identifiers

PMID26691847
PMCPMC4821755
OpenAlexW2396764878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.